The American Gastroenterological Association released new guidance for clinicians caring for patients with inflammatory bowel disease (IBD) and those performing endoscopic procedures, and two recent studies looked at GI symptoms in patients with COVID-19.
A randomized trial found that median length of hospital stay was 40.0 hours in the antibiotic group and 45.8 hours in the placebo group, with no significant between-group differences in adverse events or readmissions.
Thirty-day mortality was slightly lower among high-risk patients who underwent endoscopy for an acute upper GI bleed within 24 hours of a consult instead of within six hours, although the difference was not statistically significant.
A 25-year-old woman is evaluated for a 1-month history of intermittent, loose, bloody bowel movements associated with pain in the left lower quadrant before defecation. She reports no fever, chills, night sweats, arthralgia, eye pain, or rash. What is the most likely diagnosis?
As a result of the immediate market withdrawal request, ranitidine medications, commonly known by the brand name Zantac, will not be available for new or existing prescription or over-the-counter use in the U.S.